Microprojection array having a beneficial agent containing coating
The device including a plurality of stratum corneum-piercing microprojections, and a solid coating disposed upon the microprojections, wherein the solid coating includes at least one beneficial agent and a biocompatible carrier is provided. The device is applied to the skin of a living animal (e.g., a human), causing the microprojections to pierce the stratum corneum and deliver an effective dose of the agent to the animal.
1. A device for delivering a beneficial agent through the stratum corneum, the device comprising:
a plurality of stratum corneum-piercing microprojections;
a coating disposed as a homogenous, amorphous glassy form upon at least a portion of said microprojections,
wherein the coating is substantially dried and includes at least one beneficial agent and at least one water soluble biocompatible carrier;
wherein said agent is dissolved or suspended in said carrier,
wherein said coating is placed in contact with body fluid after the microprojections have pierced the stratum corneum, and wherein said at least one water soluble biocompatible carrier comprises human albumin.
2. The device of claim 1 , wherein said human albumin is bio-engineered human albumin.
3. The device of claim 1 , wherein the at least one beneficial agent is suspended in the at least one water soluble biocompatible carrier.
4. The device of claim 1 , wherein the at least one beneficial agent is selected from the group consisting of vaccines and desensitizing agents.
5. The device of claim 1 , wherein the ratio of all biocompatible carriers to all beneficial agents range from about 0.2:1 to about 5:1 weight/weight.
6. The device of claim 1 , wherein the ratio of all biocompatible carriers to all beneficial agents range from about 0.5:1 to about 2:1 weight/weight.
7. The device of claim 1 , wherein the coating includes a plurality of beneficial agents.
8. The device of claim 1 , wherein each of the at least one beneficial agents are included on coatings which are on separate portions of the plurality of microprojections.
9. The device of claim 1 , wherein the at least one biocompatible carrier further includes at least one carrier selected from the group consisting of sucrose, trehalose, melezitose, raffinose, and stachyose.
10. A device for delivering a beneficial agent through the stratum corneum, the device comprising:
a plurality of stratum corneum-piercing microprojections;
a coating disposed as a homogeneous, amorphous glassy form upon at least a portion of said microprojections;
wherein the coating is substantially dried and includes at least one beneficial agent and at least one water soluble biocompatible carrier;
wherein said agent is dissolved or suspended in said carrier,
wherein said coating is placed in contact with body fluid after the microprojections have pierced the stratum corneum, and
wherein the at least one water soluble biocompatible carrier is selected from the group consisting of dextran sulfate, pentosan polysulfate, polyglutamic acid, polyaspartic acid, polyhistidine, and non-reducing sugars.
11. A device for delivering a beneficial agent through the stratum corneum, the device comprising:
a plurality of stratum corneum-piercing microprojections;
a coating disposed as a homogeneous, amorphous glassy form upon at least a portion of said microprojections;
wherein the coating is substantially dried and includes at least one beneficial agent and at least one water soluble biocompatible carrier;
wherein said agent is dissolved or suspended in said carrier,
wherein said coating is placed in contact with body fluid after the microprojections have pierced the stratum corneum, and
wherein the at least one water soluble biocompatible carrier is a polyamino acid.